open access

Vol 27, No 5 (2020)
Editorial comment — COVID-19
Published online: 2020-11-06
Get Citation

Impaired microcirculation function in COVID-19 and implications for potential therapies

Aleksandra Gąsecka, Krzysztof J. Filipiak, Miłosz J. Jaguszewski
DOI: 10.5603/CJ.2020.0154
·
Pubmed: 33165898
·
Cardiol J 2020;27(5):485-488.

open access

Vol 27, No 5 (2020)
Editorial comment — COVID-19
Published online: 2020-11-06

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Impaired microcirculation function in COVID-19 and implications for potential therapies

Journal

Cardiology Journal

Issue

Vol 27, No 5 (2020)

Pages

485-488

Published online

2020-11-06

DOI

10.5603/CJ.2020.0154

Pubmed

33165898

Bibliographic record

Cardiol J 2020;27(5):485-488.

Authors

Aleksandra Gąsecka
Krzysztof J. Filipiak
Miłosz J. Jaguszewski

References (30)
  1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382(8): 727–733.
  2. Rybniker J, Fätkenheuer G. Importance of precise data on SARS-CoV-2 transmission dynamics control. Lancet Infect Dis. 2020; 20(8): 877–879.
  3. Kowalik MM, Trzonkowski P, Łasińska-Kowara M, et al. COVID-19 - Toward a comprehensive understanding of the disease. Cardiol J. 2020; 27(2): 99–114.
  4. Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res. 2020; 220: 1–13.
  5. Fox SE, Akmatbekov A, Harbert G, et al. Pulmonary and cardiac pathology in Covid-19: the first autopsy series from New Orleans. Lancet Respir Med. 2020; 8(7): 681–686.
  6. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020; 34(5): e212–e213.
  7. Zhang Y, Cao W, Xiao M, et al. Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonghua Xue Ye Xue Za Zhi. 2020; 41(4): 302–307.
  8. Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020; 183(1): 71–77.
  9. Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–847.
  10. Levi M, Thachil J, Iba JH, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; 7(6): e438–e440.
  11. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020; 141(20): 1648–1655.
  12. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis, Int. J Infect Dis. 2020.
  13. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054–1062.
  14. Lorente-Ros A, Monteagudo Ruiz JM, Rincón LM, et al. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients. Cardiol J. 2020 [Epub ahead of print].
  15. Tersalvi G, Vicenzi M, Calabretta D, et al. Elevated troponin in patients with coronavirus disease 2019: possible mechanisms. J Card Fail. 2020; 26(6): 470–475.
  16. Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020; 41(19): 1861–1862.
  17. Yang De, Han Z, Oppenheim JJ. Alarmins and immunity. Immunol Rev. 2017; 280(1): 41–56.
  18. Varga Z, Flammer A, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234): 1417–1418.
  19. Hamming I, Timens W, Bulthuis MLC, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2): 631–637.
  20. Vaduganathan M, Vardeny O, Michel T, et al. Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19. N Engl J Med. 2020; 382(17): 1653–1659.
  21. McGonagle D, O’Donnell JS, Sharif K, et al. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020; 2(7): e437–e445.
  22. Zheng YY, Ma YT, Zhang X, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020; 17(5): 259–260.
  23. Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407–477.
  24. Ferrari R, Camici PG, Crea F, et al. Expert consensus document: A 'diamond' approach to personalized treatment of angina. Nat Rev Cardiol. 2018; 15(2): 120–132.
  25. Klabunde R. Cardiovascular physiology concepts. Lippincott Williams & Wilkins 2011.
  26. Lanza G, Crea F. Primary coronary microvascular dysfunction. Circulation. 2010; 121(21): 2317–2325.
  27. Danchin N, Marzilli M, Parkhomenko A, et al. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis. Cardiology. 2011; 120(2): 59–72.
  28. Bazoukis G, Brilakis ES, Tse G, et al. The efficacy of coronary sinus reducer in patients with refractory angina-A systematic review of the literature. J Interv Cardiol. 2018; 31(6): 775–779.
  29. Banai S, Schwartz M, Sievert H, et al. Long-term follow-up to evaluate the safety of the neovasc reducer a device-based therapy for chronic refractory angina. J Am Coll Cardiol. 2010; 55(10): A98.E927.
  30. Navarese EP, Musci RL, Frediani L, et al. Ion channel inhibition against COVID-19: A novel target for clinical investigation. Cardiol J. 2020 [Epub ahead of print].

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl